Your browser doesn't support javascript.
loading
Efficacy and safety of PLDR-IMRT for the re-irradiation of recurrent NPC: A prospective, single-arm, multicenter trial.
Huang, Rui; Li, Zhihui; Yang, Fan; Zhang, Yu; Jiang, Yanhui; Li, Churong; Gao, Hui; Li, Guanghui; Liu, Yimin; Guo, Wenyan; Yang, Dingqiang; Zhang, Shichuan; Li, Jie; Wen, Hao; Lang, Jinyi; Zhang, Peng.
Afiliação
  • Huang R; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Li Z; The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
  • Yang F; Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Zhang Y; Department of Oncology, MianYang Central Hospital, Mianyang, China.
  • Jiang Y; Department of Radiotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Li C; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Gao H; The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
  • Li G; Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Liu Y; Department of Radiotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guo W; The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
  • Yang D; Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Zhang S; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Li J; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Wen H; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Lang J; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Zhang P; Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Cancer Sci ; 114(6): 2534-2543, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36788727
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Radioterapia de Intensidade Modulada / Reirradiação Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Radioterapia de Intensidade Modulada / Reirradiação Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China